PM
TBIO icon

Penbrook Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Penbrook Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,685
Closed -$141K – 106
2023
Q4 		$141K Sell
19,685
-513
-3% -$5.7K 0.1% 98
2023
Q3 		$378K Sell
20,198
-11
-0.1% -$268 0.28% 73
2023
Q2 		$575K Buy
20,209
+1,183
+6% +$47.2K 0.42% 54
2023
Q1 		$1.06M Buy
19,026
+4,090
+27% +$145K 0.81% 31
2022
Q4 		$323K Hold
14,936
– – 0.28% 74
2022
Q3 		$446K Buy
14,936
+4,587
+44% +$161K 0.38% 64
2022
Q2 		$335K Buy
10,349
+2,340
+29% +$162K 0.26% 81
2022
Q1 		$774K Buy
+8,009
New +$1.21M 0.5% 59

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DF Dent & Co
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Penbrook Management's TBIO Position: Q1 2024 in Review

Penbrook Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2024, closing a stake of 19,685 shares — an estimated $141K sold.

Penbrook Management first reported a position in TBIO in Q1 2022 and held it in 8 quarters. The position peaked at $1.06M in Q1 2023. 20 funds tracked by Wall St. Rank hold TBIO as of Q1 2024.

  • Penbrook Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Penbrook Management sold 19,685 Telesis Bio, Inc. Common Stock shares in Q1 2024, an estimated $141K.
  • Penbrook Management first reported a position in Telesis Bio, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Penbrook Management's Telesis Bio, Inc. Common Stock position peaked at $1.06M in Q1 2023.
  • 20 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2024.

Based on Penbrook Management's 13F filing for Q1 2024, filed 18 Apr 2024.